Regal Assets Analytics

Pharmaceutical & Biotechnology

Breaking Down A Potentially Novel Treatment For Cancer

By |2021-05-12T10:34:53-04:00March 25th, 2021|Categories: Healthcare, Interviews, Maj Soueidan, Pharmaceutical & Biotechnology, Video Shelf|Tags: , |

Today, we had a Zoom meeting with Anthony Cataldo, [...]

AnaptysBio (ANAB) Probability Sentiment

By |2021-01-31T17:44:12-05:00January 29th, 2021|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Anaptysbio, Inc. (NASDAQ:ANAB) Probability Sentiment [...]

Xenon Pharmaceuticals (XENE) Probability Sentiment

By |2020-12-07T10:42:27-05:00December 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Probability Sentiment [...]

SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA

By |2020-12-02T10:26:29-05:00December 2nd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

The FDA will decide on December 3 whether to approve [...]

SanaCurrents closing out Adverum Biotechnologies (ADVM)

By |2020-11-21T11:33:39-05:00November 17th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]

Adverum catalyst set for Saturday, November 14

By |2020-11-17T10:16:00-05:00November 11th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]

Calliditas’ Shares Soar About 35% After Hitting Catalyst

By |2020-11-09T12:00:46-05:00November 9th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]

Annexon, Inc. (ANNX) Probability Sentiment

By |2020-10-31T17:19:12-04:00October 31st, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: |

$ANNX Probability Sentiment FEATURED CATALYST [...]

Go to Top